EmulSol(R)

Product

Information

Ascendia Pharmaceutical Solutions offers its EmulSol(R) platform: a technology for production of oil-in-water nano-emulsions. Nano-emulsions are meta-stable and a high level of input energy is required to produce a nano-emulsion. Contact us for more information.

Distribution Areas

North America (USA, Canada)

Supplied From

United States

Main Categories

Contract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services)

All Categories

Formulation development

Ascendia Pharmaceutical Solutions

1208

Ascendia Pharmaceutical Solutions is a specialty US CDMO providing custom formulation development and manufacturing. We deliver sophisticated formulations to enhance bioavailability, solubility and stability, while reducing toxicity using GRAS (Generally Regarded As Safe) materials and 4 proprietary nanotechnologies - NanoSol, EmulSol, AmorSol and LipidSol. Following formulation selection and optimization, Ascendia can scale-up a development program quickly to cGMP manufacturing of clinical materials. Ascendia offers both aseptic and non-aseptic manufacturing for small molecules and biologics.

EmulSol(R)

Information

Log in